FI886055A - Komposition för kontrollerad utlösning av ett biologiskt aktivt material löst eller dispergerat i en L2-fas - Google Patents

Komposition för kontrollerad utlösning av ett biologiskt aktivt material löst eller dispergerat i en L2-fas Download PDF

Info

Publication number
FI886055A
FI886055A FI886055A FI886055A FI886055A FI 886055 A FI886055 A FI 886055A FI 886055 A FI886055 A FI 886055A FI 886055 A FI886055 A FI 886055A FI 886055 A FI886055 A FI 886055A
Authority
FI
Finland
Prior art keywords
dispersed
phase
composition
active material
biologically active
Prior art date
Application number
FI886055A
Other languages
English (en)
Finnish (fi)
Other versions
FI97687B (sv
FI97687C (sv
Inventor
Sven Engstroem
Kaore Viktor Larsson
Bjoern Lindman
Original Assignee
Drilletten Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drilletten Ab filed Critical Drilletten Ab
Publication of FI886055A publication Critical patent/FI886055A/sv
Publication of FI97687B publication Critical patent/FI97687B/sv
Application granted granted Critical
Publication of FI97687C publication Critical patent/FI97687C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI886055A 1986-07-01 1988-12-30 Komposition för kontrollerad utlösning av ett biologiskt aktivt material löst eller dispergerat i en L2-fas FI97687C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8602931 1986-07-01
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
SE8700279 1987-01-23
PCT/SE1987/000279 WO1988000059A1 (en) 1986-07-01 1987-06-12 A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase

Publications (3)

Publication Number Publication Date
FI886055A true FI886055A (sv) 1988-12-30
FI97687B FI97687B (sv) 1996-10-31
FI97687C FI97687C (sv) 1997-02-10

Family

ID=20364989

Family Applications (1)

Application Number Title Priority Date Filing Date
FI886055A FI97687C (sv) 1986-07-01 1988-12-30 Komposition för kontrollerad utlösning av ett biologiskt aktivt material löst eller dispergerat i en L2-fas

Country Status (8)

Country Link
EP (1) EP0314689B1 (sv)
JP (1) JPH0759523B2 (sv)
CA (1) CA1296631C (sv)
DE (1) DE3778024D1 (sv)
DK (1) DK105888D0 (sv)
FI (1) FI97687C (sv)
SE (1) SE457693B (sv)
WO (1) WO1988000059A1 (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5196201A (en) * 1989-10-20 1993-03-23 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
EP0429419B1 (en) * 1989-10-20 1996-02-14 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
AU668509B2 (en) * 1991-04-19 1996-05-09 Affinity Biotech, Inc. Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
DK0642332T3 (da) 1992-05-13 1997-06-16 Sandoz Ltd Ophthalmiske præparater indeholdende cyclosporin
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
SE518619C2 (sv) * 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
AU737053B2 (en) 1997-01-30 2001-08-09 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
TR199901008T1 (xx) * 1997-09-09 2000-02-21 Select Release, L.C. Kaplanm�� partik�ller, yap�m� ve kullan�m y�ntemleri.
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
CN114145290A (zh) * 2021-06-02 2022-03-08 贵州省烟草科学研究院 高效长效昆虫性诱芯及其制作方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1052697A (en) * 1974-03-29 1979-04-17 Upjohn Company (The) Composition for treating mastitis in animals
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung

Also Published As

Publication number Publication date
SE8602931L (sv) 1988-01-02
SE457693B (sv) 1989-01-23
JPH0759523B2 (ja) 1995-06-28
FI97687B (sv) 1996-10-31
CA1296631C (en) 1992-03-03
FI97687C (sv) 1997-02-10
SE8602931D0 (sv) 1986-07-01
DK105888A (da) 1988-02-29
DE3778024D1 (sv) 1992-05-07
EP0314689B1 (en) 1992-04-01
JPH01503140A (ja) 1989-10-26
DK105888D0 (da) 1988-02-29
EP0314689A1 (en) 1989-05-10
WO1988000059A1 (en) 1988-01-14

Similar Documents

Publication Publication Date Title
FI886055A (sv) Komposition för kontrollerad utlösning av ett biologiskt aktivt material löst eller dispergerat i en L2-fas
DK606086A (da) Transdermalt eller dermalt plaster til indgift af en kontrolleret maengde aktivt stof
KR880701115A (ko) 인공생체복합재료
GB2015464B (en) Method of encapsulating biologically active materials in lipid vesicles
FI892640A0 (sv) Förfarande för framställning av en piperidinoalkanol-ibuprofenkomposition innehållande farmaceutisk komposition
FI850620A0 (sv) N-aryl-3-aryl-4,5-dihydro-1H-pyrazol-1-karboxamider, förfarande för framställning därav och insekticidkompositioner innehållande dessa
FI890083A0 (sv) Förfarande för att torka material av växt- eller animaliskt ursprung
FI840923A0 (fi) Kristalliserad kolhydratmatris foer biologiskt aktiva substanser, saett att framstaella densamma sadess anvaendning
IT8323762A0 (it) Derivati glicosilati dell'insulina.
SE459904B (sv) Anordning foer behandling av olika material genom mekanisk bearbetning och/eller blandning
FI893959A0 (sv) Förfarande för framställning av partiklar, som innehåller ett biologiskt producerat material i en polymermatris
DK10687D0 (da) Paafoeringsmateriale til byggematerialer
FI945780A (sv) Nya biologiskt aktiva eburnameninderivat, farmaceutiska kompositioner innehållande dessa och förfarande för framställning av dessa
DK106685A (da) Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf
FI95914C (sv) Polypeptidderivat och förfarande för deras framställning
HUT42510A (en) Process for preparing biologically active derivatives of humane gamma-interferone and pharmaceutical compositions containing such compounds
FI890484A (sv) Väggmaterial för plantuppdrivningsceller
FR2598617B1 (fr) Composition pharmaceutique
GB2095260B (en) Ubstance and immunoactive composition biologically active substance process for preparing the s0
PT78571B (en) Process for preparing biologically active polypeptides and of pharmaceutical compositions containing the same
FI892144A0 (sv) Förfarande för framställning av 5-C-hydroximetylaldohexosbaserade föreningar
KR900700392A (ko) 초전도막 형성용 타아겟재
DK464686D0 (da) Praeparat med kontrolleret afgivelse af det aktive stof
HUT43316A (en) Herbicidal compositions comprising heterocyclic nitriferous compounds carrying aryl-carbomoyl groups as active substance and process for preparing the active substances
FI94417B (sv) Förfarande för framställning av farmakologiskt aktiva aminosteroider

Legal Events

Date Code Title Description
BB Publication of examined application
GB Transfer or assigment of application

Owner name: GS DEVELOPMENT AB

MM Patent lapsed

Owner name: GS DEVELOPMENT AB